---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-001611"
form_type: "8-K"
ticker: "TGNT"
cik: "0000846377"
company_name: "Totaligent, Inc."
filed_at: "2026-03-27T23:59:59+00:00"
generated_at: "2026-05-15T08:45:19.303434+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "medium"
source: SEC EDGAR
---

# Totaligent extends GloMed joint venture LOI deadline to April 22, 2026

## Summary
- Extension Amendment moves target closing date from March 22 to April 22, 2026.
- Binding exclusivity period extended through April 22, 2026.
- Delay attributed to ongoing due diligence and negotiations for definitive agreements.
- All other terms of the original LOI remain unchanged.

## SEC filing metadata
- accession: 0001477932-26-001611
- form_type: 8-K
- ticker: TGNT
- cik: 0000846377
- company_name: Totaligent, Inc.
- filed_at: 2026-03-27T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: medium
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/846377/000147793226001611/0001477932-26-001611-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/846377/000147793226001611/totaligent_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-001611
- JSON: https://secwatch.observer/filing/0001477932-26-001611.json
- Plain text: https://secwatch.observer/filing/0001477932-26-001611.txt

## Key facts
- Material Agreements
  Totaligent, Inc. amended Extension Amendment with GloMed Solutions Limited Liability Company (effective 2026-03-22).
  - Action: amendment
  - Counterparty: GloMed Solutions Limited Liability Company
  - Effective: 2026-03-22
  source text: On March 22, 2026, Totaligent, Inc. (the “Company”) entered into an Extension Amendment (the “Amendment”) to the Binding Letter of Intent dated February 22, 2026 (the “LOI”) with GloMed Solutions Limited Liability Company (“GloMed”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/846377/000147793226001611/0001477932-26-001611-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.